LifeBond
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Seed | ||
$1.5m | Series A | ||
$8.0m | Series B | ||
$20.0m | Series C | ||
$27.0m | Series D | ||
N/A | Acquisition | ||
Total Funding | €51.4m |
Recent News about LifeBond
EditLifeBond is a medical technology company specializing in advanced hemostatic solutions designed to control surgical bleeding and improve patient outcomes. Operating in the healthcare and medical devices market, LifeBond serves hospitals, surgical centers, and healthcare professionals who require reliable and effective bleeding control products. The company's business model revolves around the development, manufacturing, and distribution of its proprietary hemostatic products, which generate revenue through direct sales and partnerships with medical distributors. LifeBond's innovative products are designed to enhance surgical safety, reduce complications, and improve overall patient care, making it a valuable player in the medical technology industry.
Keywords: hemostatic solutions, surgical bleeding, patient safety, medical technology, healthcare, surgical centers, bleeding control, medical devices, innovation, patient care.